ArticleOncology letters2025

[Retracted] miR‑200b and miR‑200c co‑contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases.

Jue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.